Park Avenue Securities’s Teladoc Health TDOC Stock Holding History

Park Avenue Securities’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,015	Closed	-$266K	–	1167
2022 Q2	$266K	Sell	8,015 -5,036	-39%	-$214K	0.01%	969
2022 Q1	$941K	Sell	13,051 -2,709	-17%	-$195K	0.02%	511
2021 Q4	$1.45M	Buy	15,760 +2,059	+15%	+$246K	0.03%	345
2021 Q3	$1.74M	Buy	13,701 +2,299	+20%	+$335K	0.03%	271
2021 Q2	$1.9M	Buy	11,402 +3,913	+52%	+$634K	0.04%	238
2021 Q1	$1.36M	Buy	7,489 +2,208	+42%	+$512K	0.03%	266
2020 Q4	$1.06M	Buy	5,281 +2,492	+89%	+$507K	0.03%	274
2020 Q3	$611K	Buy	2,789 +1,517	+119%	+$321K	0.02%	388
2020 Q2	$243K	Buy	+1,272	New	+$223K	0.01%	582

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Park Avenue Securities's TDOC Position: Q3 2022 in Review

Park Avenue Securities sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 8,015 shares — an estimated $266K sold.

Park Avenue Securities first reported a position in TDOC in Q2 2020 and held it in 9 quarters. The position peaked at $1.9M in Q2 2021. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

Park Avenue Securities reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
Park Avenue Securities sold 8,015 Teladoc Health shares in Q3 2022, an estimated $266K.
Park Avenue Securities first reported a position in Teladoc Health in Q2 2020 and held it in 9 quarters.
Park Avenue Securities's Teladoc Health position peaked at $1.9M in Q2 2021.
483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Park Avenue Securities's 13F filing for Q3 2022, filed 1 Nov 2022.